Follow
CROSSJECT
Euronext Growth Paris (France)
Crossject specializes in manufacturing and marketing needleless drug self-injection.
Sector:
HEALTH CARE
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
ALCJ
FR0011716265
Euronext Growth Paris
France (FR)
Details of share in CROSSJECT with ticker ALCJ
Status
Active
Order book id
Amount of instruments
18 447 028
Par value
Market cap
Currency
EUR
Segment
Euronext Growth public offering
Terms
Type
Ticker
ISIN
Market
SHARE
ALCJ
FR0011716265
Euronext Growth Paris
France (FR)
Details of share in CROSSJECT with ticker ALCJ
Status
Active
Order book id
Amount of instruments
18 447 028
Par value
Market cap
Currency
EUR
Segment
Euronext Growth public offering
Terms
Type
Ticker
ISIN
Market
OPTION
ALCBS
FR0013434461
Euronext Growth Paris
France (FR)
Details of option in CROSSJECT with ticker ALCBS
Status
Archived
Order book id
Amount of instruments
18 447 028
Market cap
Currency
EUR
Terms
People
Patrick Alexandre
CEO
Patrick Alexandre
Chairman of the board
Company Details
Sector
HEALTH CARE

Address
6 RUE PAULINE KERGOMARD
Zip code
21000
City/district
DIJON
Country
France (FR)
Registration number
438822215
LEI code
969500W1VTFNL2D85A65
First trade date
20 Feb 2014
Registration date
24 Jul 2001
Short name
CROSSJECT
Largest shareholders

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date